GeneOne Life Science, Inc. (KRX:011000)
2,730.00
-285.00 (-9.45%)
Last updated: Jun 5, 2025
GeneOne Life Science Revenue
GeneOne Life Science had revenue of 8.50B KRW in the quarter ending March 31, 2025, with 20.93% growth. This brings the company's revenue in the last twelve months to 37.19B, down -6.65% year-over-year. In the year 2024, GeneOne Life Science had annual revenue of 35.72B, down -11.15%.
Revenue (ttm)
37.19B
Revenue Growth
-6.65%
P/S Ratio
6.22
Revenue / Employee
885.53M
Employees
42
Market Cap
231.25B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 35.72B | -4.48B | -11.15% |
Dec 31, 2023 | 40.20B | -8.52B | -17.48% |
Dec 31, 2022 | 48.72B | 10.02B | 25.89% |
Dec 31, 2021 | 38.70B | -2.80B | -6.75% |
Dec 31, 2020 | 41.50B | 261.48M | 0.63% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |